Business
Investors in drugmaker Mesoblast sweat on crucial capital raising – Sydney Morning Herald
The stem cell giant says it needs cash from its existing partnerships to ‘continue as a going concern’.
The ability of the group to continue as a going concern and realise its assets and discharge its liabilities in the normal course of business are dependent on cash inflows from successfully completing the private placement, as well as from existing strategic and financing partnerships, the auditors report said.
Analysts at Bell Potter noted last month that Mesoblasts balance sheet could come under pressure in the 2022 financial year if there were any hiccups with agreements and payments from partners…
-
Noosa News14 hours agoMassive wind farm project in Queensland axed amid community backlash
-
Business17 hours agoIAG shares are racing higher today. Here’s why
-
Noosa News15 hours agoProp Allan Alaalatoa returns to the Wallabies line-up for Rugby Championship game against Argentina
-
General19 hours agoQueensland government dumps Forest Wind project